Global Insights on Pharmaceutical Contract Manufacturing

By:
Posted: 08/09/2012

Against of backdrop of unsuccessful new drug discovery, patent expiry and a particularly tough global economic economy, the pharmaceutical industry model has had to change and over the last 10 years in the quest to remain profitable.

Pharmaceutical manufacturers have increasingly turned to the resources and experience of external companies such as contract manufacturing organisations (CMOs) to manufacture finished products in their portfolios and new drugs for clinical trials.

By:
Posted: 08/09/2012